FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2417770109> ?p ?o ?g. }

• W2417770109 endingPage "1562" @default.
• W2417770109 startingPage "1555" @default.
• W2417770109 abstract "Background: This investigation assessed the effectiveness of initiating anti-osteoporotic therapy after a fragility fracture in preventing subsequent fractures. Methods: The Truven Health MarketScan databases, which contain de-identified, integrated, person-specific claim data, were queried from 2003 to 2012. The study population included individuals fifty years of age or older who sustained a fragility fracture, defined as any fracture of the wrist, proximal part of the humerus, hip, or vertebra, and had three years of continuous enrollment following fracture. Patients were stratified into either an anti-osteoporotic therapy group or a no-treatment group. Subsequent fracture was defined as a fragility fracture occurring more than ninety days following the index fracture. Subjects were followed for three years. Unadjusted and age and sex-adjusted odds ratios for subsequent fracture were calculated for both groups. Results: This investigation included 31,069 subjects, of whom 10.6% were treated with anti-osteoporotic therapy following the index fracture. The anti-osteoporotic therapy group was older and had a greater proportion of female patients compared with the no-treatment group. The three-year subsequent fracture rates were 7.5% in the anti-osteoporotic therapy group and 9.7% in the no-treatment group. Unadjusted odds ratios for subsequent fracture showed that the anti-osteoporotic therapy group experienced a risk reduction of 33% after an index wrist fracture, 48% after an index proximal humeral fracture, 28% after an index hip fracture, 20% after an index vertebral fracture, and 25% after all fractures combined. Age and sex-adjusted odds ratios showed that the anti-osteoporotic therapy group experienced a reduction in risk of 50% after an index wrist fracture, 52% after an index proximal humeral fracture, 34% after an index hip fracture, 43% after an index vertebral fracture, and 40% after all fractures combined. The number needed to treat to prevent a subsequent fragility fracture was twenty-eight after an index wrist fracture, twenty after an index proximal humeral fracture, twenty-six after an index hip fracture, twenty-five after an index vertebral fracture, and twenty-seven after all fractures combined. Conclusions: Treatment with anti-osteoporotic therapy after a fragility fracture leads to a 40% decrease in the three-year risk of subsequent fracture, when adjusted for age and sex. Initiation of anti-osteoporotic therapy following a fragility fracture can prevent a subsequent fracture over the following three years in approximately one of every twenty-seven patients treated. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence." @default.
• W2417770109 created "2016-06-24" @default.
• W2417770109 creator A5014189698 @default.
• W2417770109 creator A5016983892 @default.
• W2417770109 creator A5085566669 @default.
• W2417770109 date "2015-10-07" @default.
• W2417770109 modified "2023-10-18" @default.
• W2417770109 title "Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture" @default.
• W2417770109 cites W1966813919 @default.
• W2417770109 cites W1979848519 @default.
• W2417770109 cites W1993035292 @default.
• W2417770109 cites W2012229907 @default.
• W2417770109 cites W2013724724 @default.
• W2417770109 cites W2015637821 @default.
• W2417770109 cites W2021907443 @default.
• W2417770109 cites W2024574150 @default.
• W2417770109 cites W2025672294 @default.
• W2417770109 cites W2026111001 @default.
• W2417770109 cites W2032093049 @default.
• W2417770109 cites W2045967931 @default.
• W2417770109 cites W2048541373 @default.
• W2417770109 cites W2050421897 @default.
• W2417770109 cites W2050587934 @default.
• W2417770109 cites W2055925669 @default.
• W2417770109 cites W2061326496 @default.
• W2417770109 cites W2064972333 @default.
• W2417770109 cites W2069518047 @default.
• W2417770109 cites W2070568974 @default.
• W2417770109 cites W2081220798 @default.
• W2417770109 cites W2107689115 @default.
• W2417770109 cites W2110467562 @default.
• W2417770109 cites W2118100789 @default.
• W2417770109 cites W2118729543 @default.
• W2417770109 cites W2124527463 @default.
• W2417770109 cites W2126771624 @default.
• W2417770109 cites W2148849217 @default.
• W2417770109 cites W2160005424 @default.
• W2417770109 cites W2161837912 @default.
• W2417770109 cites W2163830908 @default.
• W2417770109 cites W2167515284 @default.
• W2417770109 cites W2171709369 @default.
• W2417770109 cites W2321227665 @default.
• W2417770109 cites W2904877638 @default.
• W2417770109 doi "https://doi.org/10.2106/jbjs.n.01275" @default.
• W2417770109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26446962" @default.
• W2417770109 hasPublicationYear "2015" @default.
• W2417770109 type Work @default.
• W2417770109 sameAs 2417770109 @default.
• W2417770109 citedByCount "68" @default.
• W2417770109 countsByYear W24177701092015 @default.
• W2417770109 countsByYear W24177701092016 @default.
• W2417770109 countsByYear W24177701092017 @default.
• W2417770109 countsByYear W24177701092018 @default.
• W2417770109 countsByYear W24177701092019 @default.
• W2417770109 countsByYear W24177701092020 @default.
• W2417770109 countsByYear W24177701092021 @default.
• W2417770109 countsByYear W24177701092022 @default.
• W2417770109 countsByYear W24177701092023 @default.
• W2417770109 crossrefType "journal-article" @default.
• W2417770109 hasAuthorship W2417770109A5014189698 @default.
• W2417770109 hasAuthorship W2417770109A5016983892 @default.
• W2417770109 hasAuthorship W2417770109A5085566669 @default.
• W2417770109 hasConcept C126322002 @default.
• W2417770109 hasConcept C141071460 @default.
• W2417770109 hasConcept C156957248 @default.
• W2417770109 hasConcept C1862650 @default.
• W2417770109 hasConcept C2776541429 @default.
• W2417770109 hasConcept C2776886416 @default.
• W2417770109 hasConcept C2778216619 @default.
• W2417770109 hasConcept C2778885795 @default.
• W2417770109 hasConcept C2908647359 @default.
• W2417770109 hasConcept C2994343686 @default.
• W2417770109 hasConcept C71924100 @default.
• W2417770109 hasConcept C99454951 @default.
• W2417770109 hasConceptScore W2417770109C126322002 @default.
• W2417770109 hasConceptScore W2417770109C141071460 @default.
• W2417770109 hasConceptScore W2417770109C156957248 @default.
• W2417770109 hasConceptScore W2417770109C1862650 @default.
• W2417770109 hasConceptScore W2417770109C2776541429 @default.
• W2417770109 hasConceptScore W2417770109C2776886416 @default.
• W2417770109 hasConceptScore W2417770109C2778216619 @default.
• W2417770109 hasConceptScore W2417770109C2778885795 @default.
• W2417770109 hasConceptScore W2417770109C2908647359 @default.
• W2417770109 hasConceptScore W2417770109C2994343686 @default.
• W2417770109 hasConceptScore W2417770109C71924100 @default.
• W2417770109 hasConceptScore W2417770109C99454951 @default.
• W2417770109 hasIssue "19" @default.
• W2417770109 hasLocation W24177701091 @default.
• W2417770109 hasLocation W24177701092 @default.
• W2417770109 hasOpenAccess W2417770109 @default.
• W2417770109 hasPrimaryLocation W24177701091 @default.
• W2417770109 hasRelatedWork W192839043 @default.
• W2417770109 hasRelatedWork W2257295102 @default.
• W2417770109 hasRelatedWork W2379148758 @default.
• W2417770109 hasRelatedWork W2436024106 @default.
• W2417770109 hasRelatedWork W2738851661 @default.
• W2417770109 hasRelatedWork W2754372181 @default.
• W2417770109 hasRelatedWork W2980452414 @default.

• next